According to a new report by Allied Market Research, titled, World Digital Pathology Market - Opportunities and Forecasts, 2014 - 2022, the digital pathology market is projected to reach $1,052 million by 2022. North America accounted for major share in 2015 and is expected to maintain its dominance throughout the forecast period.
The market is majorly driven by growing popularity of virtual slides as compared to physical slides, technological advancements, and cost-effective products in the digital pathology segment. Other factors contributing to the growth of this market include workflow efficiency, analysis efficiency, improved productivity & patient care, and accuracy. However, the factors restraining the market growth are the lack of reimbursement policies, inadequate infrastructure, and pending product approvals.
Browse full report with TOC@ https://marketreportscenter.com/reports/358567/world-digital-pathology-market-opportunities-and-forecasts-2014-2022
Whole slide imaging is a leading segment due to its diversified use in surgical pathology, clinical diagnosis, consultation, and education. It is also used in proficiency testing, which is a part of cytopathology. The scanners/digitizers segment accounted for the largest share of the overall whole slide imaging market in 2015; while reagents is projected to be the fastest growing segment at CAGR of 15.3% during the study period.
The hospitals & diagnostic centers segment accounted for about two-fifths of the world digital pathology market in 2015, and is projected to maintain this trend throughout the forecast period. The rise is attributed to the demand for accurate and faster diagnosis along with increasing government efforts for the development of digital pathology globally. Moreover, growing trends toward the adoption of digital pathology by hospitals instead of the conventional methods is among the key factors driving the market growth.